Hardman & Co Research On NB Private Equity Partners (NBPE): 2025 CMD Good Returns From Low Risk PE Model
|
Hardman & Co Research
Hardman & Co Research on NB Private Equity Partners (NBPE): 2025 CMD good returns from low risk PE model NBPE's key takeaways from its 2025 Capital Markets day were i) high-quality portfolio (strong underlying operating performance, particularly among larger positions), ii) well positioned for improving exits (mature portfolio with a number of exit-ready companies), iii) balance sheet strength (flexibility to increase investment in attractive new opportunities in addition to returning capital to shareholders, iv) optimal access via co-investments (NB's differentiated co-investment platform provides efficient access to attractive opportunities alongside high-quality managers), and v) attractive investment pipeline (focus on mid-life co-investments providing exposure to companies already in the value-creation phase). Please click on the link below for the full report: If you are interested in meeting the company, you can register your interest by clicking on the above link.
Hardman & Co Research can still be accessed for free after MiFID II. Please click here to read the statement. About Hardman & Co: Hardman Research Ltd, trading as Hardman & Co, is an Appointed Representative of Palace Ventures Limited and is authorised and regulated by the Financial Conduct Authority; our FCA registration number is FRN 433291. Hardman Research Ltd is registered at Companies House with number 8256259. Attention is drawn to the important disclaimers at the end of the report.
Dissemination of a CORPORATE NEWS, transmitted by EQS Group. |
2239732 03-Dec-2025
Legal Disclaimer:
MENAFN provides the
information “as is” without warranty of any kind. We do not accept
any responsibility or liability for the accuracy, content, images,
videos, licenses, completeness, legality, or reliability of the information
contained in this article. If you have any complaints or copyright
issues related to this article, kindly contact the provider above.

Comments
No comment